GenSight Biologics S.A. GSGTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.59% | -103.65% | 0.43% | 25.05% | -7.85% |
| Total Depreciation and Amortization | -0.58% | -29.33% | -0.47% | 75.51% | 7.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.59% | 47.39% | -0.43% | 817.49% | 7.90% |
| Change in Net Operating Assets | -0.59% | 309.02% | 0.43% | -178.60% | 7.84% |
| Cash from Operations | 0.59% | 76.71% | 0.43% | -181.14% | -7.84% |
| Capital Expenditure | 0.52% | -1,578.26% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -100.87% | -0.43% | 560.13% | -7.89% |
| Cash from Investing | 0.75% | -129.35% | -0.44% | 552.49% | -7.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 80.44% | 0.00% | -154.24% | 0.00% |
| Issuance of Common Stock | 0.00% | -82.96% | 0.00% | 652.90% | 0.00% |
| Repurchase of Common Stock | 0.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -93.89% | 0.00% | 7,006.78% | 0.00% |
| Cash from Financing | -0.58% | -88.42% | -0.43% | 2,756.88% | 7.89% |
| Foreign Exchange rate Adjustments | 0.60% | -3,823.53% | 5.56% | -140.00% | 7.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00% | 200.00% | -20.00% |
| Net Change in Cash | 0.60% | -134.80% | -0.43% | 200.76% | -7.85% |